top of page

Publications

Original Article

Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant

Tumor Microenvironment

2013

Authors:

Engel AL, Sun GC, Gad E, Rastetter LR, Strobe K, Yang Y, Dang Y, Disis ML, Lu H

Journal:

immunobiology

Volume:

218(12)

Page:

1468-76

Original Article

Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women

Cancer Diagnostics

2013

Authors:

Ladd JJ, Chao T, Johnson MM, Qiu J, Chin A, Israel R, Pitteri SJ, Mao J, Wu M, Amon LM, McIntosh MW, Li CI, Prentice R, Disis NL, Hanash SM.

Journal:

Cancer Research

Volume:

73(5)

Page:

1502-13

Original Article

Identification of putative immunologic targets for colon cancer prevention based on conserved gene upregulation from preinvasive to malignant lesions

Cancer Vaccines

2013

Authors:

Broussard, E.K., Kim, R., Wiley, J.C., Pritchard, D., Marquez, J.P., Annis, J.E., and Disis, M.L.

Journal:

Cancer Prevention Research

Volume:

6(7)

Page:

666-74

Review Article

The invisible arm of immunity in common cancer chemoprevention agents

2013

Authors:

Marzbani E, Inatsuka C, Lu H, Disis ML.

Journal:

Cancer Prevention Research

Volume:

6(8)

Page:

764-73

Review Article

Values in translation: how asking the right questions can move translational science toward greater health impact

2012

Authors:

Kelley M, Edwards K, Starks H, Fullerton SM, James R, Goering S, Holland S, Disis ML, Burke W.

Journal:

Clinical and Translational Science

Volume:

5(6)

Page:

445-51

Original Article

Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs

Cancer Vaccines

2012

Authors:

Kievit, FM, Stephen, ZR, Veiseh, O, Arami, H, Wang, T, Lai, VP, Park, JO, Ellenbogen, RG, Disis, ML, and Zhang, M

Journal:

ACS Nano

Volume:

6(3)

Page:

2591-601

Original Article

VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC

Tumor Microenvironment

2012

Authors:

Lu H., Dietsch G. N., Matthews M. A., Yang Y., Ghanekar S., Inokuma M., Suni M., Maino V. C., Henderson K. E., Howbert J. J., Disis M. L., Hershberg R. M.

Journal:

Clinical Cancer Research

Volume:

18(2)

Page:

499-509

Original Article

Dendritic cell-activating vaccine adjuvants differ in the ability to elicit antitumor immunity due to an adjuvant-specific induction of immunosuppressive cells

Tumor Microenvironment

2012

Authors:

Dang Y, Wagner WM, Gad E, Rastetter L, Berger CM, Holt GE, Disis ML.

Journal:

Clinical Cancer Research

Volume:

18(11)

Page:

3122-31

Original Article

Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera

Cancer Diagnostics

2012

Authors:

Lu H, Ladd J, Feng Z, Wu M, Goodell V, Pitteri SJ, Li CI, Prentice R, Hanash SM, Disis ML.

Journal:

Cancer Prevention Research

Volume:

5(8)

Page:

1036-43

Original Article

Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer

Cancer Diagnostics

2012

Authors:

Amon LM, Pitteri SJ, Li CI, McIntosh M, Ladd JJ, Disis M, Porter P, Wong CH, Zhang Q, Lampe P, Prentice RL, Hanash SM.

Journal:

Cancer Research

Volume:

72(8)

Page:

1935-42

bottom of page